US Stock MarketDetailed Quotes
BLRX BioLine Rx
- 0.850
- -0.022-2.48%
Close Jul 26 16:00 ET
- 0.890
- +0.040+4.71%
Post 19:23 ET
67.95MMarket Cap-1133P/E (TTM)
0.890High0.813Low484.65KVolume0.873Open0.872Pre Close414.72KTurnover0.67%Turnover RatioLossP/E (Static)79.94MShares2.53052wk High5.21P/B61.90MFloat Cap0.51052wk Low--Dividend TTM72.83MShs Float103.050Historical High--Div YieldTTM8.83%Amplitude0.510Historical Low0.855Avg Price1Lot Size
BioLine Rx Stock Forum
Sign in to post a comment
$BioLine Rx(BLRX.US$ Benzinga· 1 min ago
BioLineRx Announces Multi-Center Phase 1 Trial Sponsored By St. Jude Children's Research Hospital To Evaluate Motixafortide For CD34+ Hematopoietic Stem Cell Mobilization For Gene Therapy Applications In Sickle Cell Disease
BioLineRx Announces Multi-Center Phase 1 Trial Sponsored By St. Jude Children's Research Hospital To Evaluate Motixafortide For CD34+ Hematopoietic Stem Cell Mobilization For Gene Therapy Applications In Sickle Cell Disease
5
4
$BioLine Rx(BLRX.US$ BioLineRx To Present Poster On Economic Model Data For APHEXDA Today At ISPOR 2024
$BioLine Rx(BLRX.US$ BioLineRx Has Drawn-down The Second Tranche Of $20M Under Its Previously Announced $40M Non-Dilutive Debt Financing Agreement With Funds And Accounts Managed By Blackrock
$BioLine Rx(BLRX.US$ BioLineRx Announces Notice of Allowance for U.S. Patent Covering Method of Manufacturing Motixafortide (BL-8040) Suitable for Large Scale Production, New Patent, When Issued, Will Be Valid Until December 2041
HC Wainwright & Co. Reiterates Buy on BioLine Rx, Maintains $21 Price Target: A Deep Dive into the Potential of $BLRX.
BioLine Rx (NASDAQ: $BLRX), an Israeli biopharmaceutical development company, recently received a reiterated buy rating from the renowned investment bank, HC Wainwright & Co. The financial institution has maintained a price target of $21 for BioLine Rx, indicating a positive outlook for the company's futur...
BioLine Rx (NASDAQ: $BLRX), an Israeli biopharmaceutical development company, recently received a reiterated buy rating from the renowned investment bank, HC Wainwright & Co. The financial institution has maintained a price target of $21 for BioLine Rx, indicating a positive outlook for the company's futur...
2
$BioLine Rx(BLRX.US$ just let it run already. this is silly. youre picking up cents and it wants to move dollars 🤦🏻♂️
$BioLine Rx(BLRX.US$ BioLineRx Entered Exclusive License Agreement To Motixafortide In Asia, Advisored By M.S.Q. Ventures; Provides $15M Upfront And Equity Investment Of $14.6M, Up To $50M In Development And Regulatory Milestones, Up To $200M In Commercial Milestones
Benzinga· 3 mins ago![]()
Benzinga· 3 mins ago
1
$Apollomics(APLM.US$
$Prestige Wealth(PWM.US$ $Guardforce AI(GFAI.US$ $Intuitive Machines(LUNR.US$ $Amesite(AMST.US$ $Tenax Therapeutics(TENX.US$ $Buzzfeed(BZFD.US$ $COMSovereign(COMS.US$ $Minerva Surgical(UTRS.US$ $Ault Alliance(AULT.US$ $AMTD Digital(HKD.US$ $Micromobility.com(MCOM.US$ $Cadrenal Therapeutics(CVKD.US$ $Genius Group(GNS.US$ $BBBYQ$ $Cosmos Health(COSM.US$ $Panbela Therapeutics(PBLA.US$ $APGN$ $Annexon(ANNX.US$ $Golden Sun Health Technology(GSUN.US$ $Laser Photonics(LASE.US$ $Cemtrex(CETX.US$ $Troika Media(TRKA.US$ $NextPlay Technologies(NXTP.US$ $China Pharma(CPHI.US$ $Dianthus Therapeutics(DNTH.US$ $Nuwellis(NUWE.US$ $OpGen(OPGN.US$ $Powerbridge Technologies(PBTS.US$ $Healthcare Triangle(HCTI.US$ $Digital Brands Group(DBGI.US$ $Kintara Therapeutics(KTRA.US$ $Ensysce Biosciences(ENSC.US$ $Houston American Energy(HUSA.US$ $AlTi Global(ALTI.US$ $Zovio(ZVOI.US$ $Agrify(AGFY.US$ $Oblong(OBLG.US$ $SOBR Safe(SOBR.US$ $Nauticus Robotics(KITT.US$ $Avenue Therapeutics(ATXI.US$ $Blue Apron(APRN.US$ $Bright Minds Biosciences Inc(DRUG.CA$ $Applied DNA Sciences(APDN.US$ $Magic Empire Global(MEGL.US$ $Evolve Transition Infrastructure(SNMP.US$ $Vivos Therapeutics(VVOS.US$ $American Strategic Investment(NYC.US$ $Icecure Medical(ICCM.US$ $Applied Uv(AUVI.US$ $ShiftPixy(PIXY.US$ $Tempest Therapeutics(TPST.US$ $Tupperware Brands(TUP.US$ $Applied Uv(AUVI.US$ $Yield10 Bioscience(YTEN.US$ $Assure(IONM.US$ $Versus Systems(VS.US$ $The Alkaline Water(WTER.US$ $TC BioPharm(TCBP.US$ $Unicycive Therapeutics(UNCY.US$ $Peraso(PRSO.US$ $PARTS iD(ID.US$ $FTSE Singapore Straits Time Index(.STI.SG$ $Ascent Solar Technologies(ASTI.US$ $Abri SPAC I(ASPA.US$ $Connexa Sports Technologies(CNXA.US$ $Unique Fabricating(UFAB.US$ $Aditxt(ADTX.US$ $PainReform(PRFX.US$ $Alpha Technology(ATGL.US$ $Urgent.ly(ULY.US$ $Bruush Oral Care(BRSH.US$ $ReShape Lifesciences(RSLS.US$ $Appreciate Holdings(SFR.US$ ...
$Prestige Wealth(PWM.US$ $Guardforce AI(GFAI.US$ $Intuitive Machines(LUNR.US$ $Amesite(AMST.US$ $Tenax Therapeutics(TENX.US$ $Buzzfeed(BZFD.US$ $COMSovereign(COMS.US$ $Minerva Surgical(UTRS.US$ $Ault Alliance(AULT.US$ $AMTD Digital(HKD.US$ $Micromobility.com(MCOM.US$ $Cadrenal Therapeutics(CVKD.US$ $Genius Group(GNS.US$ $BBBYQ$ $Cosmos Health(COSM.US$ $Panbela Therapeutics(PBLA.US$ $APGN$ $Annexon(ANNX.US$ $Golden Sun Health Technology(GSUN.US$ $Laser Photonics(LASE.US$ $Cemtrex(CETX.US$ $Troika Media(TRKA.US$ $NextPlay Technologies(NXTP.US$ $China Pharma(CPHI.US$ $Dianthus Therapeutics(DNTH.US$ $Nuwellis(NUWE.US$ $OpGen(OPGN.US$ $Powerbridge Technologies(PBTS.US$ $Healthcare Triangle(HCTI.US$ $Digital Brands Group(DBGI.US$ $Kintara Therapeutics(KTRA.US$ $Ensysce Biosciences(ENSC.US$ $Houston American Energy(HUSA.US$ $AlTi Global(ALTI.US$ $Zovio(ZVOI.US$ $Agrify(AGFY.US$ $Oblong(OBLG.US$ $SOBR Safe(SOBR.US$ $Nauticus Robotics(KITT.US$ $Avenue Therapeutics(ATXI.US$ $Blue Apron(APRN.US$ $Bright Minds Biosciences Inc(DRUG.CA$ $Applied DNA Sciences(APDN.US$ $Magic Empire Global(MEGL.US$ $Evolve Transition Infrastructure(SNMP.US$ $Vivos Therapeutics(VVOS.US$ $American Strategic Investment(NYC.US$ $Icecure Medical(ICCM.US$ $Applied Uv(AUVI.US$ $ShiftPixy(PIXY.US$ $Tempest Therapeutics(TPST.US$ $Tupperware Brands(TUP.US$ $Applied Uv(AUVI.US$ $Yield10 Bioscience(YTEN.US$ $Assure(IONM.US$ $Versus Systems(VS.US$ $The Alkaline Water(WTER.US$ $TC BioPharm(TCBP.US$ $Unicycive Therapeutics(UNCY.US$ $Peraso(PRSO.US$ $PARTS iD(ID.US$ $FTSE Singapore Straits Time Index(.STI.SG$ $Ascent Solar Technologies(ASTI.US$ $Abri SPAC I(ASPA.US$ $Connexa Sports Technologies(CNXA.US$ $Unique Fabricating(UFAB.US$ $Aditxt(ADTX.US$ $PainReform(PRFX.US$ $Alpha Technology(ATGL.US$ $Urgent.ly(ULY.US$ $Bruush Oral Care(BRSH.US$ $ReShape Lifesciences(RSLS.US$ $Appreciate Holdings(SFR.US$ ...
11
18
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
Sean Parker : let's hope it goes up when the market opens. doesn't seem like people are interested yet
.
Trytosaveabit OP Sean Parker : True! Hard to say if they will like it? GL
Sean Parker Trytosaveabit OP : I feel like it's good news all around. plus with a 21PT I'm not sure how .7 doesn't seem like a good buy. I know I sold what I could and bought in.
Trytosaveabit OP Sean Parker : Right! Can’t say that I disagree with your assessment! Hehehe